Robert Young Kim - Net Worth and Insider Trading

Robert Young Kim Net Worth

The estimated net worth of Robert Young Kim is at least $8,516 dollars as of 2024-11-05. Robert Young Kim is the Chief Medical Officer of 4D Molecular Therapeutics Inc and owns about 1,043 shares of 4D Molecular Therapeutics Inc (FDMT) stock worth over $8,516. Details can be seen in Robert Young Kim's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Young Kim has not made any transactions after 2024-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Young Kim

To

Robert Young Kim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Young Kim owns 1 companies in total, including 4D Molecular Therapeutics Inc (FDMT) .

Click here to see the complete history of Robert Young Kim’s form 4 insider trades.

Insider Ownership Summary of Robert Young Kim

Ticker Comapny Transaction Date Type of Owner
FDMT 4D Molecular Therapeutics Inc 2024-02-05 Chief Medical Officer

Robert Young Kim Latest Holdings Summary

Robert Young Kim currently owns a total of 1 stock. Robert Young Kim owns 1,043 shares of 4D Molecular Therapeutics Inc (FDMT) as of February 5, 2024, with a value of $8,516.

Latest Holdings of Robert Young Kim

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FDMT 4D Molecular Therapeutics Inc 2024-02-05 1,043 8.17 8,516

Holding Weightings of Robert Young Kim


Robert Young Kim Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Young Kim has made a total of 1 transactions in 4D Molecular Therapeutics Inc (FDMT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in 4D Molecular Therapeutics Inc is the sale of 24,552 shares on February 5, 2024, which brought Robert Young Kim around $737,788.

Insider Trading History of Robert Young Kim

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Young Kim Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Young Kim Ownership Network

Ownership Network List of Robert Young Kim

No Data

Ownership Network Relation of Robert Young Kim

Insider Network Chart

Robert Young Kim Owned Company Details

What does 4D Molecular Therapeutics Inc do?

Who are the key executives at 4D Molecular Therapeutics Inc?

Robert Young Kim is the Chief Medical Officer of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and 10 percent owner Viking Global Investors Lp .

4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary

Over the past 18 months, Robert Young Kim made 1 insider transaction in 4D Molecular Therapeutics Inc (FDMT) with a net sale of 24,552. Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net sale of 225,853 shares made by David Kirn , and a net purchase of 310,000 shares made by Viking Global Investors Lp .

In summary, during the past 3 months, insiders sold 1,000 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 1,000 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 850,000 shares were bought by its insiders, resulting in a net purchase of 19,712 shares.

4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

4D Molecular Therapeutics Inc Insider Transactions

No Available Data

Robert Young Kim Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Young Kim. You might contact Robert Young Kim via mailing address: C/o 4d Molecular Therapeutics, Inc., 5858 Horton Street #455, Emeryville Ca 94608.